Trials / Completed
CompletedNCT02238210
Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy
A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) With Rhinorrhea Associated With a Common Cold or Allergy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 2 Years – 5 Years
- Healthy volunteers
- Not accepted
Summary
Study to determine the safety of Atrovent Nasal Spray 0.06% in pediatric patients (ages 2-5 years) with symptoms of rhinorrhea associated with a naturally occurring common cold or from symptoms of rhinorrhea associated with allergies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atrovent® |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2003-05-01
- First posted
- 2014-09-12
- Last updated
- 2014-09-12
Source: ClinicalTrials.gov record NCT02238210. Inclusion in this directory is not an endorsement.